<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02692261</url>
  </required_header>
  <id_info>
    <org_study_id>KA-14030</org_study_id>
    <nct_id>NCT02692261</nct_id>
  </id_info>
  <brief_title>Hyaluronic Matrix Efficacy for Maxillary Sinus Augmentation</brief_title>
  <official_title>Evaluation of Hyaluronic Matrix, Used With Xenograft, Efficacy in Sinus Augmentation by Histomorphometry and Micro Computed Tomography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hacettepe University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hacettepe University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sinus augmentation is a predictable method when alveolar bone height is not sufficient for
      dental implant placement in posterior maxillary alveolar region..The aim of this prospective,
      randomized, controlled clinical study is comparison of hyaluronic acid originated matrix and
      equine derived xenograft with only xenograft use in sinus augmentation by micro computed
      tomography and histomorphometry.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2014</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of newly formed bone calculated from bone biopsises by Micro-CT and Histomorphometry</measure>
    <time_frame>4 months after surgery</time_frame>
    <description>Biological parameter obtained by analyzing bone biopsises</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">13</enrollment>
  <condition>Sinus; Dental</condition>
  <arm_group>
    <arm_group_label>Hyalossᵀᴹ matrix</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Each 0.5 cc Collagenated Heterolog Bone Graft, mixed with two bundles of Hyalossᵀᴹ matrix and a few drops of sterile saline solution used for maxillary sinus augmentation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Apatos alone xenograft</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Each sinus was filled with 1 gr xenograft (with or without Hyaluronic Acide) for maxillary sinus augmentation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Maxillary Sinus Augmentation</intervention_name>
    <description>Each 0.5 cc Collagenated Heterolog Bone Graft, mixed with two bundles of Hyalossᵀᴹ matrix and a few drops of sterile saline solution</description>
    <arm_group_label>Hyalossᵀᴹ matrix</arm_group_label>
    <arm_group_label>Apatos alone xenograft</arm_group_label>
    <other_name>Hyaloss matrix</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Maxillary Sinus Augmentation</intervention_name>
    <description>Control group sinuses filled with heterolog bone graft alone</description>
    <arm_group_label>Hyalossᵀᴹ matrix</arm_group_label>
    <arm_group_label>Apatos alone xenograft</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Systemically healthy patients

          -  Requiring bilateral maxillary sinus augmentation (residual crest height ≤ 4 mm)

        Exclusion Criteria:

          -  Advanced systemic diseases

          -  Chronic medication use

          -  Maxillary sinus disease

          -  Current pregnancy

          -  Lactation

          -  Smoking habit
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>33 Years</minimum_age>
    <maximum_age>69 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Feriha Caglayan, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Hacettepe University</affiliation>
  </overall_official>
  <link>
    <url>http://www.pubmed.com</url>
  </link>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 17, 2016</study_first_submitted>
  <study_first_submitted_qc>February 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 26, 2016</study_first_posted>
  <last_update_submitted>February 22, 2016</last_update_submitted>
  <last_update_submitted_qc>February 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hacettepe University</investigator_affiliation>
    <investigator_full_name>EZGİ DOĞAN</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

